Total medical devices industry deals worth $11bn were announced globally for September 2022, with the CVS Health’s $8bn acquisition deal with Signify Health being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 85.02% over the previous month of $5.94bn and a drop of 14.1% when compared with the last 12-month average of $12.8bn.
In terms of number of deals, the sector saw a drop of 9.66% with 187 deals in September 2022 when compared to the last 12-month average of 207 deals.
In value terms, North America led the activity with deals worth $10.32bn in September 2022.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMedical Devices industry deals in September 2022: Top deals
The top five deals accounted for 86.7% of the overall value during September 2022.
The combined value of the top five deals stood at $9.53bn, against the overall value of $11bn recorded for the month.
The top five medical devices industry deals of September 2022 tracked by GlobalData were:
1) CVS Health’s $8bn acquisition deal with Signify Health
2) The $875m acquisition of Rx Savings Solutions by McKesson
3) Orbimed Advisors’s $250m private equity deal with Adaptive Biotechnologies
4) The $243.32m acquisition of Medi-Globe by DCC Healthcare
5) HartBeat Ventures, North Castle Partners and Rx3 Ventures’s $165m private equity deal with Theragun
